DarioHealth Presents New Analysis Demonstrating the Impression of a Digital Answer on Despair and Nervousness on the American Psychological Affiliation Annual Conference
The research underscore the worth of Dario’s built-in behavioral well being answer to assist extra folks connect with efficient care that’s proper for his or her wants
NEW YORK, Aug. 4, 2022 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO), a pacesetter within the international digital therapeutics (DTx) market, introduced right now new analysis offered on the American Psychological Affiliation (“APA”) Annual Conference being held August 4th to sixth, 2022 in Minneapolis, Minnesota and nearly.
Folks residing with persistent situations are 2 to three instances extra more likely to expertise melancholy or nervousness than these residing with out a persistent sickness, and untreated melancholy or nervousness usually results in poor well being outcomes. Dario’s unified digital therapeutics platform ensures that folks with melancholy or nervousness, particularly these residing with persistent sicknesses, are capable of join with handy and efficient care that contributes to enhancing their well being.
The most recent analysis from Dario examined the affect of a digital behavioral well being answer for folks residing with clinically elevated ranges of melancholy. The analysis findings demonstrated a wide-scale affect, with 72% of customers lowering their signs of melancholy throughout 12 weeks of participation. Furthermore, 44% of customers within the research skilled clinically important reductions of their ranges of melancholy throughout the identical timeframe.
In an extra research carried out by Dario, it was noticed that 68% of individuals residing with extreme or reasonable nervousness improved their signs following 12 weeks of using the platform, and 40% of members with extreme ranges of hysteria skilled a clinically important discount in the course of the analysis interval.
“Despair, nervousness and persistent situations have a sophisticated and bidirectional relationship, making it essential to make sure Dario members are receiving the care they should assist handle each. Our newest research present additional proof that our options present members with the care they should assist enhance their general well being with efficient, handy digital instruments,” stated Yifat Hershcovitz, PhD., Vice President of Medical and Scientific Affairs at Dario and supervisor of the research.
“Therapy for melancholy and nervousness in folks with persistent situations are recognized to be predictors of higher general well being. Dario approaches this downside with an entire well being, built-in answer for persistent situation administration, and we’re proud to see that that is making a distinction for our members,” stated Omar Manejwala, MD, Chief Medical Officer at Dario.
You’ll be able to be taught extra in regards to the APA Conference by visiting their web site at https://conference.apa.org.
About DarioHealth Corp.
DarioHealth Corp. (NASDAQ:DRIO) is a number one digital therapeutics (DTx) firm revolutionizing how folks with persistent situations handle their well being by means of a user-centric multi-chronic situation platform. Our platform and suite of options ship customized and dynamic interventions pushed by knowledge analytics and one-on-one teaching for diabetes, hypertension, weight administration, musculoskeletal ache, and behavioral well being.
Our user-centric platform gives folks steady and customised take care of well being, disrupting the standard episodic strategy to healthcare. This strategy empowers folks to holistically adapt their existence for sustainable habits change, driving distinctive consumer satisfaction, retention, and outcomes. Making the fitting factor to do the straightforward factor to do.
Dario gives its extremely consumer rated options globally to well being plans and different payors, self-insured employers, suppliers of care and on to customers. To be taught extra about DarioHealth and its digital well being options, or for extra data, go to http://dariohealth.com.
Cautionary Notice Concerning Ahead-Trying Statements
This information launch and the statements of representatives and companions of DarioHealth Corp. associated thereto include or might include forward-looking statements inside the that means of the Non-public Securities Litigation Reform Act of 1995. Statements that aren’t statements of historic reality could also be deemed to be forward-looking statements. For instance, the Firm is utilizing forward-looking statements on this press launch when it discusses the potential advantages which may be realized by customers using the Dario platform. With out limiting the generality of the foregoing, phrases similar to “plan,” “challenge,” “potential,” “search,” “might,” “will,” “count on,” “imagine,” “anticipate,” “intend,” “might,” “estimate” or “proceed” are supposed to determine forward-looking statements. Readers are cautioned that sure necessary components might have an effect on the Firm’s precise outcomes and will trigger such outcomes to vary materially from any forward-looking statements which may be made on this information launch. Elements that will have an effect on the Firm’s outcomes embody, however aren’t restricted to, regulatory approvals, product demand, market acceptance, affect of aggressive merchandise and costs, product improvement, commercialization or technological difficulties, the success or failure of negotiations and commerce, authorized, social and financial dangers, and the dangers related to the adequacy of current money assets. Extra components that might trigger or contribute to variations between the Firm’s precise outcomes and forward-looking statements embody, however aren’t restricted to, these dangers mentioned within the Firm’s filings with the U.S. Securities and Alternate Fee. Readers are cautioned that precise outcomes (together with, with out limitation, the timing for and outcomes of the Firm’s industrial and regulatory plans for Dario™ as described herein) might differ considerably from these set forth within the forward-looking statements. The Firm undertakes no obligation to publicly replace any forward-looking statements, whether or not on account of new data, future occasions or in any other case, besides as required by relevant regulation.
DarioHealth Company Contact
Suzanne Bedell
VP Advertising and marketing
[email protected]
+1-347-767-4220
Media Contact:
Scott Stachowiak
[email protected]
+1-646-942-5630
Emblem – http://mma.prnewswire.com/media/544126/DarioHealth_Logo.jpg
SOURCE DarioHealth Corp.
